Amicus Therapeutics Inc Net Asset Quality Index
Amicus Therapeutics Inc net asset quality index. Amicus Therapeutics Inc (FOLD) has a Net Asset Quality Index of 28.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $949.87 Million minus total liabilities of $675.63 Million yields net assets of $274.24 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Amicus Therapeutics Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Amicus Therapeutics Inc (2003–2025)
Net asset quality index of Amicus Therapeutics Inc from 2003 to 2025. This chart shows how Amicus Therapeutics Inc's Net Asset Quality Index has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the index stands at 28.9%, representing net assets of $274.24 Million against total assets of $949.87 Million USD. Check Amicus Therapeutics Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Amicus Therapeutics Inc Net Asset Quality Index by Year (2003–2025)
Amicus Therapeutics Inc net asset quality index by year from 2003 to 2025. The table below presents the year-by-year Net Asset Quality Index for Amicus Therapeutics Inc from 2003 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see FOLD stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 28.9% | $274.24 Million | $949.87 Million | $675.63 Million | ▲ +4.2 pp |
| 2024 | 24.7% | $194.04 Million | $785.03 Million | $590.99 Million | ▲ +4.1 pp |
| 2023 | 20.6% | $160.17 Million | $777.88 Million | $617.71 Million | ▲ +3.6 pp |
| 2022 | 17.0% | $123.05 Million | $724.17 Million | $601.12 Million | ▼ -17.0 pp |
| 2021 | 34.0% | $307.37 Million | $905.14 Million | $597.77 Million | ▲ +1.7 pp |
| 2020 | 32.3% | $286.38 Million | $886.52 Million | $600.14 Million | ▼ -23.7 pp |
| 2019 | 56.0% | $476.43 Million | $850.21 Million | $373.78 Million | ▲ +12.6 pp |
| 2018 | 43.4% | $342.91 Million | $789.95 Million | $447.04 Million | ▼ -12.9 pp |
| 2017 | 56.3% | $352.85 Million | $627.02 Million | $274.17 Million | ▲ +21.5 pp |
| 2016 | 34.7% | $360.15 Million | $1.04 Billion | $676.69 Million | ▼ -3.6 pp |
| 2015 | 38.3% | $347.83 Million | $908.38 Million | $560.55 Million | ▼ -19.9 pp |
| 2014 | 58.2% | $122.18 Million | $209.97 Million | $87.79 Million | ▲ +22.3 pp |
| 2013 | 35.9% | $45.75 Million | $127.56 Million | $81.81 Million | ▼ -27.0 pp |
| 2012 | 62.9% | $69.22 Million | $110.09 Million | $40.87 Million | ▲ +20.5 pp |
| 2011 | 42.4% | $29.59 Million | $69.80 Million | $40.20 Million | ▼ -15.3 pp |
| 2010 | 57.7% | $64.93 Million | $112.55 Million | $47.62 Million | ▼ -26.5 pp |
| 2009 | 84.1% | $71.83 Million | $85.37 Million | $13.54 Million | ▲ +29.0 pp |
| 2008 | 55.2% | $71.04 Million | $128.77 Million | $57.73 Million | ▼ -6.6 pp |
| 2007 | 61.8% | $103.30 Million | $167.10 Million | $63.80 Million | ▲ +191.8 pp |
| 2006 | -130.0% | $-77.52 Million | $59.65 Million | $137.16 Million | ▼ -5.0 pp |
| 2005 | -125.0% | $-35.83 Million | $28.67 Million | $64.50 Million | ▼ -206.8 pp |
| 2004 | 81.8% | $4.15 Million | $5.07 Million | $922.00K | ▲ +1134.7 pp |
| 2003 | -1052.9% | $-5.28 Million | $501.00K | $5.78 Million | — |